Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

SRx Health Solutions (SRXH) FCF Margin (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed FCF Margin for 11 consecutive years, with 38.32% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, FCF Margin fell 3743.0% year-over-year to 38.32%, compared with a TTM value of 20.62% through Sep 2025, down 1674.0%, and an annual FY2023 reading of 0.2%, up 3817.0% over the prior year.
  • FCF Margin was 38.32% for Q2 2025 at SRx Health Solutions, down from 5.27% in the prior quarter.
  • Across five years, FCF Margin topped out at 17.24% in Q4 2023 and bottomed at 45.94% in Q1 2022.
  • Average FCF Margin over 5 years is 17.03%, with a median of 20.47% recorded in 2024.
  • The sharpest move saw FCF Margin surged 4509bps in 2023, then plummeted -3743bps in 2025.
  • Year by year, FCF Margin stood at 34.29% in 2021, then grew by 19bps to 27.85% in 2022, then surged by 162bps to 17.24% in 2023, then tumbled by -56bps to 7.62% in 2024, then tumbled by -603bps to 38.32% in 2025.
  • Business Quant data shows FCF Margin for SRXH at 38.32% in Q2 2025, 5.27% in Q1 2025, and 7.62% in Q4 2024.